ArticleInternal medicine (Tokyo, Japan)2022

Durvalumab-associated Late-onset Myocarditis Successfully Treated with Corticosteroid Therapy.

Tomoki Maetani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.